Roslyn Isseroff, M.D.

Roslyn Rivkah Isseroff, M.D.

Specialties

Dermatology

Department

Dermatology

Title

  • Distinguished Professor
  • Chief, Dermatology Section, VA Northern California

Reviews

To see if Roslyn Rivkah Isseroff is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

Mather VA Mental Health

10535 Hospital Way
Mather, CA 95755
Driving Directions

Primary Phone:

Additional Phone Numbers

Clinic Referral Phone: 800-382-8387
Physician Referrals: 800-4-UCDAVIS (800-482-3284)

Philosophy of Care

At our VA clinic, are able to provide the best care for our veterans.

Clinical Interests

Dr. Isseroff is a clinician/investigator, with clinical practice in the area of chronic,non-healing wounds. Her clinical research examines drugs and devices to improve wound healing. Her laboratory research is focussed on tissue repair and regeneration.

Research/Academic Interests

Dr. Isseroff's research focuses on tissue repair and regeneration. She has translated her laboratory work on beta blockers to the clinic, where this is now being widely adapted to improve healing. Her work in the Institute for Regenerative Cures focuses on building bioengineered tissue using stem cells to rebuild wounds.

Division

Dermatology

Education

M.D., Albert Einstein College of Medicine, Bronx NY 1975

B.S., Brooklyn College, Brooklyn College, City University of New York, Brooklyn NY 1971

Internship: Pediatrics, Babies Hospital, Colombia Presbyterian Medical Center, New York NY 1976

Residency

Dermatology, New York University Medical Center, New York NY 1976-1979

Fellowships

Cell Biology, New York University Medical Center, New York NY 1978-1979

Board Certifications

American Board of Dermatology, 1980

State of California, Medical license,

State of New York, Medical license,

Professional Memberships

Society of Investigative Dermatology

Wound Healing Society

Honors and Awards

Visiting Professor, Northwell Health, 2015

Dean's Award for Mentoring, UC Davis, 2008

Fogarty Senior International Fellowship, NIH, 1995, 1996

Research Career Development Award, 1988, 1989, 1990, 1991, 1992, 1993

Alpha Omega Alpha, 1986

Phi Beta Kappa, 1971

Select Recent Publications

To view a detailed list of  Dr. Isseroff's publications, please click here.

Fregoso DR, Hadian Y, Gallegos AC, Degovics D, Maaga J, Keogh CE, Kletenik I, Gareau MG, Isseroff RR. Skin-brain axis signaling mediates behavioral changes after skin wounding. Brain Behav Immun Health. 2021 May 28;15:100279. doi:10.1016/j.bbih.2021.100279. PMID:34589779.

Bagood MD, Isseroff RR. TRPV1: Role in Skin and Skin Diseases and Potential Target for Improving Wound Healing. Int J Mol Sci. 2021 Jun 7;22(11):6135. doi:10.3390/ijms22116135. PMID:34200205.

Yoon DJ, Nguyen C, Bagood MD, Fregoso DR, Yang HY, Medina Lopez AI, Crawford RW, Tran J, Isseroff RR. Topical Fluoxetine as a Potential Nonantibiotic Adjunctive Therapy for Infected Wounds. J Invest Dermatol. 2021 Jun;141(6):1608-1612.e3. doi:10.1016/j.jid.2020.11.016. Epub 2020 Dec 15. PMID:33338500.

Yang HY, Fierro F, So M, Yoon DJ, Nguyen AV, Gallegos A, Bagood MD, Rojo-Castro T, Alex A, Stewart H, Chigbrow M, Dasu MR, Peavy TR, Soulika AM, Nolta JA, Isseroff RR. Combination product of dermal matrix, human mesenchymal stem cells, and timolol promotes diabetic wound healing in mice. Stem Cells Transl Med. 2020 Nov;9(11):1353-1364. doi:10.1002/sctm.19-0380. Epub 2020 Jul 28. PMID:32720751.

Yoon DJ, Kaur R, Gallegos A, West K, Yang H, Schaefer S, Tchanque-Fossuo C, Dahle SE, Isseroff RR. Adverse effects of topical timolol: Safety concerns and implications for dermatologic use. J Am Acad Dermatol. 2021 Jan;84(1):199-200. doi:10.1016/j.jaad.2020.04.101. Epub 2020 Apr 25. PMID:32344067.

Siegel D, Joo JS, Cortez RA, Furlong TA, Isseroff RR. Access to Mohs micrographic surgery through the Veterans Choice Program of the United States Department of Veterans Affairs. J Am Acad Dermatol. 2020 Sep;83(3):949-950. doi:10.1016/j.jaad.2020.01.051. Epub 2020 Jan 29. PMID:32006603.

Marusina AI, Merleev AA, Luna JI, Olney L, Haigh NE, Yoon D, Guo C, Ovadia EM, Shimoda M, Luxardi G, Boddu S, Lal NN, Takada Y, Lam KS, Liu R, Isseroff RR, Le S, Nolta JA, Kloxin AM, Maverakis E. Tunable hydrogels for mesenchymal stem cell delivery: Integrin-induced transcriptome alterations and hydrogel optimization for human wound healing. Stem Cells. 2020 Feb;38(2):231-245. doi:10.1002/stem.3105. Epub 2019 Nov 23. PMID:31648388.

Nguyen CM, Tartar DM, Bagood MD, So M, Nguyen AV, Gallegos A, Fregoso D,Serrano J, Nguyen D, Degovics D, Adams A, Harouni B, Fuentes JJ, Gareau MG,Crawford RW, Soulika AM, Isseroff RR. Topical Fluoxetine as a Novel TherapeuticThat Improves Wound Healing in Diabetic Mice. Diabetes. 2019Jul;68(7):1499-1507. doi:10.2337/db18-1146. Epub 2019 May 2. PMID:31048368.

Larsen L, Tchanque-Fossuo CN, Gorouhi F, Boudreault D, Nguyen C, Fuentes JJ, Crawford RW, Dahle SE, Whetzel T, Isseroff RR. Combination therapy of autologous Adipose mesenchymal stem cell-enriched, high-density lipoaspirate and topical timolol for healing chronic wounds. J Tissue Eng Regen Med. 2018 Jan;12(1):186-190. doi:10.1002/term.2390. Epub 2017 Aug 17. PMID:27943665.